Oxygen-sensing in tumors

Current Opinion in Clinical Nutrition and Metabolic Care

Volumn 9, Issue 4, 2006, Pages 366-378

  Verma, Ajay ^a,b  

^a UNIFORMED SERVICES UNIVERSITY OF THE HEALTH SCIENCES   (United States)

^b Uniformed Services University of the Health Sciences   (United States)

Author keywords

Crabtree effect; Dioxygenase; Electron transport; Energy homeostasis; Hemoprotein; Hypoxia; Hypoxia inducible factor 1; Oxidoreductase; Pasteur effect; Pyruvate; Warburg effect

Indexed keywords

2 (2 NITRO 1H IMIDAZOL 1 YL) N (2,2,3,3,3 PENTAFLUOROPROPYL)ACETAMIDE; 2 OXOGLUTARIC ACID; DIOXYGENASE; GLUCOSE; GROWTH FACTOR; HEME; HYPOXIA INDUCIBLE FACTOR 1; IRON; MESSENGER RNA; OXYGEN; PHOSPHOTRANSFERASE; PIMONIDAZOLE; REACTIVE OXYGEN METABOLITE;

ALPHA CHAIN; ANGIOGENESIS; BIOAVAILABILITY; BIOENERGY; CANCER; CANCER CELL; CANCER CHEMOTHERAPY; CANCER INVASION; CELL COMPARTMENTALIZATION; CELL HYPOXIA; CELL MEMBRANE; CELL METABOLISM; CELL SPECIFICITY; COMPREHENSION; ENDOPLASMIC RETICULUM; ENZYME REGULATION; EVOLUTIONARY ADAPTATION; GENE EXPRESSION REGULATION; GENE MUTATION; GLUCOSE METABOLISM; HUMAN; HYDROXYLATION; HYPERGLYCEMIA; MAMMAL; METABOLITE; MITOCHONDRION; MOLECULAR DYNAMICS; MOLECULAR MECHANICS; NONHUMAN; OXIDATIVE STRESS; OXYGEN SENSING; PROTEIN STABILITY; REVIEW; RNA TRANSCRIPTION; RNA TRANSLATION; SENSITIVITY ANALYSIS; TREATMENT OUTCOME;

ADAPTATION, PHYSIOLOGICAL; CELL HYPOXIA; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; MIXED FUNCTION OXYGENASES; NEOPLASMS; OXYGEN; OXYGEN CONSUMPTION; SIGNAL TRANSDUCTION;

MAMMALIA;

EID: 33746253907     PISSN: 13631950     EISSN: 15353885     Source Type: Journal    
DOI: 10.1097/01.mco.0000232895.28674.79     Document Type: Review

References (101)

1. Vaupel P, Harrison L. Tumor hypoxia: causative factors, compensatory mechanisms, and cellular response. Oncologist 2004; 9 (Suppl 5):4-9.
2. Evans SM, Koch CJ. Prognostic significance of tumor oxygenation in humans. Cancer Lett 2003; 195:1-16.
3. Brat DJ, Van Meir EG. Vaso-occlusive and prothrombotic mechanisms associated with tumor hypoxia, necrosis, and accelerated growth in glioblastoma. Lab Invest 2004; 84:397-405.
4. Carmeliet P. VEGF as a key mediator of angiogenesis in cancer. Oncology 2005; 69 (Suppl 3):4-10.
5. Cairns RA, Khokha R, Hill RP. Molecular mechanisms of tumor invasion and metastasis: an integrated view. Curr Mol Med 2003; 3:659-671.
6. Wenger RH, Stiehl DP, Camenisch G. Integration of oxygen signaling at the consensus HRE. Sci STKE 2005; 2005:re12. A comprehensive review of HIF-1 regulated genes and signaling pathways converging on the hypoxia-recognition element.
7. Rockwell S. Oxygen delivery: implications for the biology and therapy of solid tumors. Oncol Res 1997; 9:383-390.
8. Semenza GL. Targeting HIF-1 for cancer therapy. Nat Rev Cancer 2003; 3:721-732.
9. Wang GL, Semenza GL. General involvement of hypoxia-inducible factor 1 in transcriptional response to hypoxia. Proc Natl Acad Sci U S A 1993; 90:4304-4308.
10. Zhong H, De Marzo AM, Laughner E, et al. Overexpression of hypoxia-inducible factor 1α in common human cancers and their metastases. Cancer Res 1999; 59:5830-5835.
11. Chun YS, Kim MS, Park JW. Oxygen-dependent and -independent regulation of HIF-1alpha. J Korean Med Sci 2002; 17:581-588.
12. Maxwell PH, Wiesener MS, Chang GW, et al. The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis. Nature 1999; 399:271-275.
13. Kim WY, Kaelin WG. Role of VHL gene mutation in human cancer. J Clin Oncol 2004; 22:4991-5004.
14. 2 sensing. Science 2001; 292:464-468.
15. 2-regulated prolyl hydroxylation. Science 2001; 292:468-472.
16. Bruick RK. McKnight SL A conserved family of prolyl-4-hydroxylases that modify HIF. Science 2001; 294:1337-1340.
17. Epstein AC, Gleadle JM, McNeill LA, et al. C. elegans EGL-9 and mammalian homologs define a family of dioxygenases that regulate HIF by prolyl hydroxylation. Cell 2001; 107:43-54.
18. Lando D, Peet DJ, Gorman JJ, et al. FIH-1 is an asparaginyl hydroxylase enzyme that regulates the transcriptional activity of hypoxia-inducible factor. Genes Dev 2002; 16:1466-1471.
19. To KK, Huang LE. Suppression of hypoxia-inducible factor 1alpha (HIF-1alpha) transcriptional activity by the HIF prolyl hydroxylase EGLN1. J Biol Chem 2005; 280:38102-38107. An additional function of HPH-2 in blocking HIF-1-mediated transcription is shown.
20. Hirsila M, Koivunen P, Gunzler V, et al. Characterization of the human prolyl 4-hydroxylases that modify the hypoxia-inducible factor. J Biol Chem 2003; 278:30772-30780.
21. Huang J, Zhao Q, Mooney SM, Lee FS. Sequence determinants in hypoxia-inducible factor-1α for hydroxylation by the prolyl hydroxylases PHD1, PHD2, and PHD3. J Biol Chem 2002; 277:39792-39800.
22. Chan DA, Sutphin PD, Yen SE, Giaccia AJ. Coordinate regulation of the oxygen-dependent degradation domains of hypoxia-inducible factor 1 alpha. Mol Cell Biol 2005; 25:6415-6426.
23. Appelhoff RJ, Tian YM, Raval RR, et al. Differential function of the prolyl hydroxylases PHD1, PHD2, and PHD3 in the regulation of hypoxia-inducible factor. J Biol Chem 2004; 279:38458-38465.
24. Baek JH, Mahon PC, Oh J, et al. OS-9 interacts with hypoxia-inducible factor 1alpha and prolyl hydroxylases to promote oxygen-dependent degradation of HIF-1alpha. Mol Cell 2005; 17:503-512.
25. Masson N, Appelhoff RJ, Tuckerman JR, et al. The HIF prolyl hydroxylase PHD3 is a potential substrate of the TRiC chaperonin. FEBS Lett 2004; 570:166-170.
26. Hopfer U, Hopfer H, Jablonski K, et al. The novel WD-repeat protein Morg1 acts as a molecular scaffold for hypoxia-inducible factor prolyl hydroxylase 3 (PHD3). J Biol Chem 2006; 281:8645-8655.
27. Metzen E, Berchner-Pfannschmidt U, Stengel P, et al. Intracellular localisation of human HIF-1α hydroxylases: implications for oxygen sensing. J Cell Sci 2003; 116:1319-1326.
28. Berra E, Benizri E, Ginouves A, et al. HIF prolyl-hydroxylase 2 is the key oxygen sensor setting low steady-state levels of HIF-1α in normoxia. EMBO J 2003; 22:4082-4090.
29. del Peso L, Castellanos MC, Temes E, et al. The von Hippel Lindau/hypoxia-inducible factor (HIF) pathway regulates the transcription of the HIF-proline hydroxylase genes in response to low oxygen. J Biol Chem 2003; 278:48690-48695.
30. Jokilehto T, Rantanen K, Luukkaa M, et al. Overexpression and nuclear translocation of hypoxia-inducible factor prolyl hydroxylase PHD2 in head and neck squamous cell carcinoma is associated with tumor aggressiveness. Clin Cancer Res 2006; 12:1080-1087.
31. Hanauske-Abel HM, Popowicz AM. The HAG mechanism: a molecular rationale for the therapeutic application of iron chelators in human diseases involving the 2-oxoacid utilizing dioxygenases. Curr Med Chem 2003; 10:1005-1019.
32. Schofield CJ, Ratcliffe PJ. Oxygen sensing by HIF hydroxylases. Nat Rev Mol Cell Biol 2004; 5:343-354.
33. Lu H, Forbes RA, Verma A. Hypoxia-inducible factor 1 activation by aerobic glycolysis implicates the Warburg effect in carcinogenesis. J Biol Chem 2002; 277:23111-23115.
34. Lu H, Dalgard CL, Mohyeldin A, et al. Reversible inactivation of HIF-1 prolyl hydroxylases allows cell metabolism to control basal HIF-1. J Biol Chem 2005; 280:41928-41939. This paper provides evidence for reversible inactivation of HPHs as a regulatory mechanism used by metabolites and ROS for activating HIF-1.
35. Dalgard CL, Lu H, Mohyeldin A, Verma A. Endogenous 2-oxoacids differentially regulate expression of oxygen sensors. Biochem J 2004; 380:419-424.
36. Knowles HJ, Raval RR, Harris AL, Ratcliffe PJ. Effect of ascorbate on the activity of hypoxia-inducible factor in cancer cells. Cancer Res 2003; 63:1764-1768.
37. Majamaa K, Gunzler V, Hanauske-Abel HM, et al. Partial identity of the 2-oxoglutarate and ascorbate binding sites of prolyl 4-hydroxylase. J Biol Chem 1986; 261:7819-7823.
38. Majamaa K, Turpeenniemi-Hujanen TM, Latipaa P, et al. Differences between collagen hydroxylases and 2-oxoglutarate dehydrogenase in their inhibition by structural analogues of 2-oxoglutarate. Biochem J 1985; 229:127-133.
39. Kaule G, Timpl R, Gaill F, Gunzler V. Prolyl hydroxylase activity in tissue homogenates of annelids from deep sea hydrothermal vents. Matrix Biol 1998; 17:205-212.
40. Warburg O. About the metabolism of tumors. Berlin: Springer; 1926.
41. Lee MS, Moon EJ, Lee SW, et al. Angiogenic activity of pyruvic acid in in vivo and in vitro angiogenesis models. Cancer Res 2001; 61:3290-3293.
42. Walenta S, Mueller-Klieser WF. Lactate: mirror and motor of tumor malignancy. Semin Radiat Oncol 2004; 14:267-274.
43. Walenta S, Snyder S, Haroon ZA, et al. Tissue gradients of energy metabolites mirror oxygen tension gradients in a rat mammary carcinoma model. Int J Radiat Oncol Biol Phys 2001; 51:840-848.
44. Walenta S, Wetterling M, Lehrke M, et al. High lactate levels predict likelihood of metastases, tumor recurrence, and restricted patient survival in human cervical cancers. Cancer Res 2000; 60:916-921.
45. Brizel DM, Schroeder T, Scher RL, et al. Elevated tumor lactate concentrations predict for an increased risk of metastases in head-and-neck cancer. Int J Radiat Oncol Biol Phys 2001; 51:349-353.
46. Koukourakis MI, Giatromanolaki A, Harris AL, Sivridis E. Comparison of metabolic pathways between cancer cells and stromal cells in colorectal carcinomas: a metabolic survival role for tumor-associated stroma. Cancer Res 2006; 66:632-637.
47. Selak MA, Armour SM, MacKenzie ED, et al. Succinate links TCA cycle dysfunction to oncogenesis by inhibiting HIF-alpha prolyl hydroxylase. Cancer Cell 2005; 7:77-85. A novel role is identified for the TCA cycle metabolites succinate and fumarate in regulating HIF-1.
48. Isaacs JS, Jung YJ, Mole DR, et al. HIF overexpression correlates with biallelic loss of fumarate hydratase in renal cancer: novel role of fumarate in regulation of HIF stability. Cancer Cell 2005; 8:143-153. A novel role is identified for the TCA cycle metabolites succinate and fumarate in regulating HIF-1.
49. Pollard PJ, Briere JJ, Alam NA, et al. Accumulation of Krebs cycle intermediates and over-expression of HIF1alpha in tumours which result from germline FH and SDH mutations. Hum Mol Genet 2005; 14:2231-2239. A novel role is identified for the TCA cycle metabolites succinate and fumarate in regulating HIF-1.
50. Gottlieb E, Tomlinson IP. Mitochondrial tumour suppressors: a genetic and biochemical update. Nat Rev Cancer 2005; 5:857-866. A timely review on the novel role of mitochondrial proteins playing tumor suppressor roles through metabolic signaling mechanisms.
51. MacDonald PE, Joseph JW, Rorsman P. Glucose-sensing mechanisms in pancreatic beta-cells. Philos Trans R Soc Lond B Biol Sci 2005; 360:2211-2225.
52. Kietzmann T, Gorlach A. Reactive oxygen species in the control of hypoxia-inducible factor-mediated gene expression. Semin Cell Dev Biol 2005; 16:474-486. Thorough coverage of the evidence and controversies regarding ROS signaling mechanisms in relation to HIF-1 activation.
53. Gerald D, Berra E, Frapart YM, et al. JunD reduces tumor angiogenesis by protecting cells from oxidative stress. Cell 2004; 118:781-794.
54. Brune B, Zhou J. The role of nitric oxide (NO) in stability regulation of hypoxia inducible factor-1alpha (HIF-1alpha). Curr Med Chem 2003; 10:845-855.
55. Quintero M, Brennan PA, Thomas GJ, Moncada S. Nitric oxide is a factor in the stabilization of hypoxia-inducible factor-1alpha in cancer: role of free radical formation. Cancer Res 2006; 66:770-774.
56. Moeller BJ, Cao Y, Li CY, Dewhirst MW. Radiation activates HIF-1 to regulate vascular radiosensitivity in tumors: role of reoxygenation, free radicals, and stress granules. Cancer Cell 2004; 5:429-441.
57. Callapina M, Zhou J, Schmid T, et al. NO restores HIF-1alpha hydroxylation during hypoxia: role of reactive oxygen species. Free Radic Biol Med 2005; 39:925-936.
58. Bell EL, Emerling BM, Chandel NS. Mitochondrial regulation of oxygen sensing. Mitochondrion 2005; 5:322-332. An excellent review of the evidence for and gaps in knowledge regarding a role for mitochondrial ROS in HIF-1 regulation.
59. Brunelle JK, Bell EL, Quesada NM, et al. Oxygen sensing requires mitochondrial ROS but not oxidative phosphorylation. Cell Metab 2005; 1:409-414. Provides important evidence that mitochondrial ROS production is required for HIF-1 regulation during hypoxia, but not anoxia.
60. Guzy RD, Hoyos B, Robin E, et al. Mitochondrial complex III is required for hypoxia-induced ROS production and cellular oxygen sensing. Cell Metab 2005; 1:401-408. Provides important evidence that mitochondrial ROS production is required for HIF-1 regulation during hypoxia, but not anoxia.
61. Mansfield KD, Guzy RD, Pan Y, et al. Mitochondrial dysfunction resulting from loss of cytochrome c impairs cellular oxygen sensing and hypoxic HIF-alpha activation. Cell Metab 2005; 1:393-399. Provides important evidence that mitochondrial ROS production is required for HIF-1 regulation during hypoxia, but not anoxia.
62. Patel MS, Korotchkina LG. Regulation of the pyruvate dehydrogenase complex. Biochem Soc Trans 2006; 34:217-222. A thorough yet succinct review of the regulation of the pyruvate dehydrogenase complex.
63. Vordermark D, Kraft P, Katzer A, et al. Glucose requirement for hypoxic accumulation of hypoxia-inducible factor-1alpha (HIF-1alpha). Cancer Lett 2005; 230:122-133.
64. Hon T, Dodd A, Dirmeier R, et al. A mechanism of oxygen sensing in yeast: multiple oxygen-responsive steps in the heme biosynthetic pathway affect Hap1 activity. J Biol Chem 2003; 278:50771-50780.
65. Igarashi K, Sun J. The heme-bach1 pathway in the regulation of oxidative stress response and erythroid differentiation. Antioxid Redox Signal 2006; 8:107-118.
66. Verma A, Nye JS, Snyder SH. Porphyrins are endogenous ligands for the mitochondrial (peripheral-type) benzodiazepine receptor. Proc Natl Acad Sci U S A 1987; 84:2256-2260.
67. Maaser K, Grabowski P, Oezdem Y, et al. Up-regulation of the peripheral benzodiazepine receptor during human colorectal carcinogenesis and tumor spread. Clin Cancer Res 2005; 11:1751-1756.
68. Verma A, Facchina SL, Hirsch DJ, et al. Photodynamic tumor therapy: mitochondrial benzodiazepine receptors as a therapeutic target. Mol Med 1998; 4:40-45.
69. Yeliseev AA, Krueger KE, Kaplan S. A mammalian mitochondrial drug receptor functions as a bacterial 'oxygen' sensor. Proc Natl Acad Sci U S A 1997; 94:5101-5106.
70. Pesce A, De Sanctis D, Nardini M, et al. Reversible hexa- to penta-coordination of the heme Fe atom modulates ligand binding properties of neuroglobin and cytoglobin. IUBMB Life 2004; 56:657-664.
71. Wakasugi K, Nakano T, Morishima I. Oxidized human neuroglobin acts as a heterotrimeric Galpha protein guanine nucleotide dissociation inhibitor. J Biol Chem 2003; 278:36505-36512.
72. McRonald FE, Liloglou T, Xinarianos G, et al. Downregulation of the cytoglobin gene, located on 17q25, in tylosis with oesophageal cancer (TOC): evidence for trans-allele repression. Hum Mol Genet 2006; 15:1271-1277. An intriguing paper suggesting a role for novel hemoproteins in cancer.
73. Verma A, Hirsch DJ, Glatt CE, et al. Carbon monoxide: a putative neural messenger. Science 1993; 259:381-384.
74. Kim HP, Ryter SW, Choi AM. CO as a cellular signaling molecule. Annu Rev Pharmacol Toxicol 2006; 46:411-449.
75. Suh GY, Jin Y, Yi AK, et al. CCAAT/enhancer-binding protein mediates carbon monoxide-induced suppression of cyclooxygenase-2. Am J Respir Cell Mol Biol 2006; 16 March [Epub ahead of print]. A novel mechanism for carbon monoxide-mediated signaling is introduced.
76. Huang LE, Willmore WG, Gu J, et al. Inhibition of hypoxia-inducible factor 1 activation by carbon monoxide and nitric oxide: implications for oxygen sensing and signaling. J Biol Chem 1999; 274:9038-9044.
77. Prabhakar NR. Endogenous carbon monoxide in control of respiration. Respir Physiol 1998; 114:57-64.
78. Williams SE, Wootton P, Mason HS, et al. Hemoxygenase-2 is an oxygen sensor for a calcium-sensitive potassium channel. Science 2004; 306:2093-2097.
79. He L, Dinger B, Sanders K, et al. Effect of p47phox gene deletion on ROS production and oxygen sensing in mouse carotid body chemoreceptor cells. Am J Physiol Lung Cell Mol Physiol 2005; 289:L916-L924.
80. Paulding WR, Czyzyk-Krzeska MF. Hypoxia-induced regulation of mRNA stability. Adv Exp Med Biol 2000; 475:111-121.
81. Wouters BG, van den Beucken T, Magagnin MG, et al. Control of the hypoxic response through regulation of mRNA translation. Semin Cell Dev Biol 2005; 16:487-501. Excellent and insightful review of translational control by hypoxia.
82. Feldman DE, Chauhan V, Koong AC. The unfolded protein response: a novel component of the hypoxic stress response in tumors. Mol Cancer Res 2005; 3:597-605.
83. Bi M, Naczki C, Koritzinsky M, et al. ER stress-regulated translation increases tolerance to extreme hypoxia and promotes tumor growth. EMBO J 2005; 24:3470-3481. Uses elegant approaches to demonstrate that the mRNA expression and protein expression responses are differentially regulated under hypoxia to produce a unique and restricted proteomic response.
84. Koritzinsky M, Magagnin MG, van den Beucken T, et al. Gene expression during acute and prolonged hypoxia is regulated by distinct mechanisms of translational control. EMBO J 2006; 25:1114-1125. Uses elegant approaches to demonstrate that the mRNA expression and protein expression responses are differentially regulated under hypoxia to produce a unique and restricted proteomic response.
85. Liu L, Cash TP, Jones RG, et al. Hypoxia-induced energy stress regulates mRNA translation and cell growth. Mol Cell 2006; 21:521-531.
86. Brown GK. Pyruvate dehydrogenase E1 alpha deficiency. J Inherit Metab Dis 1992; 15:625-633.
87. Eboli ML, Pasquini A. Transformation linked decrease of pyruvate dehydrogenase complex in human epidermis. Cancer Lett 1994; 85:239-243.
88. McFate T, Mohyeldin A, Henriques J, Verma A. Pyruvate dehydrogenase phosphorylation in the Warburg effect. Society for Neuroscience Program No. 442.6; 2005.
89. Pasteur L. Experiments and novel views on the nature of fermentation. Comp Rend Acad Sci 1861; 52:1260-1264.
90. Crabtree HG. Observations on the carbohydrate metabolism of tumours. Biochem J 1929; 23:536-545.
91. Passonneau JV, Lowry OH. Phosphofructokinase and the Pasteur effect. Biochem Biophys Res Commun 1962; 7:10-15.
92. Hardie DG. Metabolic control: a new solution to an old problem. Curr Biol 2000; 10:R757-R759.
93. Semenza GL, Roth PH, Fang HM, Wang GL. Transcriptional regulation of genes encoding glycolytic enzymes by hypoxia-inducible factor 1. J Biol Chem 1994; 269:23757-23763.
94. Seagroves TN, Ryan HE, Lu H, et al. Transcription factor HIF-1 is a necessary mediator of the Pasteur effect in mammalian cells. Mol Cell Biol 2001; 21:3436-3444.
95. Papandreou I, Cairns RA, Fontana L, et al. HIF-1 mediates adaptation to hypoxia by actively downregulating mitochondrial oxygen consumption. Cell Metab 2006; 3:187-197. Implicates an HIF-1-mediated mechanism for potentially regulating pyruvate dehydrogenase activity and therefore mitochondrial oxygen consumption.
96. Kim JW, Tchernyshyov I, Semenza GL, Dang CV. HIF-1-mediated expression of pyruvate dehydrogenase kinase: a metabolic switch required for cellular adaptation to hypoxia. Cell Metab 2006; 3:177-185. Implicates an HIF-1-mediated mechanism for potentially regulating pyruvate dehydrogenase activity and therefore mitochondrial oxygen consumption.
97. Piruat JI, Lopez-Barneo J. Oxygen tension regulates mitochondrial DNA-encoded complex I gene expression. J Biol Chem 2005; 280:42676-42684. A novel effect of hypoxia in reducing mitochondrial electron transport chain activity is shown to be mediated by a decrease in gene expression from mitochondrial DNA.
98. Dahia PL, Ross KN, Wright ME, et al. A HIF1alpha regulatory loop links hypoxia and mitochondrial signals in pheochromocytomas. PLoS Genet 2005; 1:72-80.
99. Prabu SK, Anandatheerthavarada HK, Raza H, et al. Protein kinase A-mediated phosphorylation modulates cytochrome c oxidase function and augments hypoxia and myocardial ischemia-related injury. J Biol Chem 2006; 281:2061-2070.
100. Habelhah H, Laine A, Erdjument-Bromage H, et al. Regulation of 2-oxoglutarate (alpha-ketoglutarate) dehydrogenase stability by the RING finger ubiquitin ligase Siah. J Biol Chem 2004; 279:53782-53788.
101. Rapp K, Schroeder J, Klenk J, et al. Fasting blood glucose and cancer risk in a cohort of more than 140,000 adults in Austria. Diabetologia 2006; 49:945-952.